BRD2 and hyperprolactinemia: The concomitant clinical manifestations of anorexia, malaise, and weight loss suggest the possible hypopituitarism by the pituitary tumor as evidenced by the endocrine data with low basal levels of pituitary hormones (ACTH, TSH, GH, LH, and FSH) and hyperprolactinemia.